CAS: 97456-81-0 - Benzene,1-bromo-3-iodo-2-methyl-
Formula:C7H6BrI
- Synonyms:
- 2-Bromo-6-Iodotoluene
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1-Bromo-3-iodo-2-methylbenzene REF: IN-DA0038J0CAS: 97456-81-0 | 97% | 21.00 €~252.00 € | Fri 13 Dec 24 |
 | 1-Bromo-3-iodo-2-methylbenzene REF: 54-OR61090CAS: 97456-81-0 | 97% | 42.00 €~189.00 € | Mon 16 Dec 24 |
 | 2-Bromo-6-iodotoluene REF: 10-F037475CAS: 97456-81-0 | 97.0% | To inquire | Mon 23 Dec 24 |
 | 1-Bromo-3-iodo-2-methylbenzene REF: 3D-FB143561CAS: 97456-81-0 | Min. 95% | - - - | Discontinued product |
1-Bromo-3-iodo-2-methylbenzene
CAS:97456-81-0
Formula:
C7H6BrI
Purity:
97%
Color and Shape:
Liquid
Molecular weight:
296.9310
Ref: IN-DA0038J0
| 1g | 24.00 € | ||
| 5g | 56.00 € | ||
| 10g | 76.00 € | ||
| 25g | 140.00 € | ||
| 100g | 252.00 € | ||
| 100mg | 21.00 € | ||
| 250mg | 25.00 € |
Estimated delivery in United States, on Friday 13 Dec 2024
1-Bromo-3-iodo-2-methylbenzene
CAS:97456-81-0
Formula:
C7H6BrI
Purity:
97%
Color and Shape:
yellow. orange liquid
Molecular weight:
296.93g/mol
Ref: 54-OR61090
| 1g | 42.00 € | ||
| 5g | 104.00 € | ||
| 10g | 189.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
2-Bromo-6-iodotoluene
CAS:97456-81-0
Purity:
97.0%
Color and Shape:
Liquid
Molecular weight:
296.9330139160156
Ref: 10-F037475
| 1g | 20.00 € | ||
| 5g | 39.00 € | ||
| 10g | 56.00 € | ||
| 25g | 119.00 € | ||
| 50g | 230.00 € | ||
| 100g | 393.00 € | ||
| 500g | To inquire | ||
| 250mg | 24.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
1-Bromo-3-iodo-2-methylbenzene
CAS:97456-81-0
1-Bromo-3-iodo-2-methylbenzene is a tyrosine kinase inhibitor that inhibits the activity of tyrosine kinases. It has …
Formula:
C7H6BrI
Purity:
Min. 95%
Molecular weight:
296.93 g/mol
Ref: 3D-FB143561
| 1g | Discontinued | Request information | |
| 2g | Discontinued | Request information | |
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 25g | Discontinued | Request information |
